tranexamic acid has been researched along with Cancer of Liver in 8 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To control the hemorrhagic diathesis, we commenced combination therapy for DIC with danaparoid (1,250 Ux2/day, intravenously (IV)) and tranexamic acid (0." | 7.73 | Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. ( Asakura, H; Matsui, O; Nakao, S; Omote, M; Ontachi, Y; Yoshida, T, 2005) |
| " To control the hemorrhagic diathesis, we commenced combination therapy for DIC with danaparoid (1,250 Ux2/day, intravenously (IV)) and tranexamic acid (0." | 3.73 | Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. ( Asakura, H; Matsui, O; Nakao, S; Omote, M; Ontachi, Y; Yoshida, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Jaffer, AA | 2 |
| Karanicolas, PJ | 2 |
| Davis, LE | 1 |
| Behman, R | 1 |
| Hanna, SS | 1 |
| Law, CH | 1 |
| Coburn, NG | 1 |
| Roke, R | 1 |
| Lemke, M | 1 |
| Beyfuss, KA | 1 |
| Hallet, J | 2 |
| Yuan, C | 1 |
| Jia, HD | 1 |
| Tong, XM | 1 |
| Liu, JW | 1 |
| Dibiasi, C | 1 |
| Wiegele, M | 1 |
| Gratz, J | 1 |
| Huang, GC | 1 |
| Chen, LJ | 1 |
| Liu, HC | 1 |
| Chen, YJ | 1 |
| Fuentes García, D | 1 |
| Ramírez Muñoz, G | 1 |
| Ontachi, Y | 1 |
| Asakura, H | 1 |
| Omote, M | 1 |
| Yoshida, T | 1 |
| Matsui, O | 1 |
| Nakao, S | 1 |
| Wu, CC | 1 |
| Ho, WM | 1 |
| Cheng, SB | 1 |
| Yeh, DC | 1 |
| Wen, MC | 1 |
| Liu, TJ | 1 |
| P'eng, FK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Tranexamic Acid on Blood Loss and Transfusion Rates in Major Oncologic Surgery[NCT01980355] | 76 participants (Actual) | Interventional | 2012-06-12 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Surgical blood loss estimation (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge
| Intervention | mL (Median) |
|---|---|
| Tranexamic Acid | 450 |
| Placebo | 365 |
To determine the impact of perioperative administration of tranexamic acid on blood loss and transfusion rates in major oncologic surgery (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 8 |
| Placebo | 5 |
1 trial available for tranexamic acid and Cancer of Liver
| Article | Year |
|---|---|
Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Chi-Square Distribution; Dou | 2006 |
7 other studies available for tranexamic acid and Cancer of Liver
| Article | Year |
|---|---|
The impact of tranexamic acid on administration of red blood cell transfusions for resection of colorectal liver metastases.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Colorectal Neoplasms; Erythrocyte Transfusion; Hepate | 2021 |
Effect of administration of tranexamic acid on reduced risk of red blood cell transfusion after resection for colorectal liver metastases.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Colorectal Neoplasms; Erythrocyte Transfusion; Humans | 2021 |
Effect of administration of tranexamic acid on reduced risk of red blood cell transfusion after resection for colorectal liver metastases - Reply.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Colorectal Neoplasms; Erythrocyte Transfusion; Humans | 2021 |
Orthotopic liver transplantation in a patient receiving apixaban for portal vein thrombosis.
Topics: Aged; Blood Loss, Surgical; Carcinoma, Hepatocellular; Dabigatran; Humans; Infusions, Intravenous; L | 2019 |
Development of vitreous haemorrhage during treatment with bevacizumab for metastatic rectal cancer.
Topics: Adenocarcinoma; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2008 |
[Type A hemophilia in a man undergoing liver resection for metastasis: implications for anesthetic management].
Topics: Adenocarcinoma; Aged; Anesthesia, General; Blood Loss, Surgical; Colorectal Neoplasms; Deamino Argin | 2009 |
Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid.
Topics: Adult; Antifibrinolytic Agents; Blood Proteins; Chondroitin Sulfates; Dermatan Sulfate; Disseminated | 2005 |